home / stock / abbv / abbv news


ABBV News and Press, AbbVie Inc. From 02/04/26

Stock Information

Company Name: AbbVie Inc.
Stock Symbol: ABBV
Market: NYSE
Website: abbvieinvestor.com

Menu

Get ABBV Alerts

News, Short Squeeze, Breakout and More Instantly...

ABBV - AbbVie posts Q4 beat as Humira outperforms

2026-02-04 08:24:03 ET More on AbbVie AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript AbbVie: The Dividend Does Not Lie AbbVie: Rocky Near-Term, Positive Long-Term AbbVie Non-GAAP EPS of $2.71 beats by $0.06, revenue of...

ABBV - Earnings Snapshot: AbbVie tops Q4 estimates; initiates FY26 outlook above forecast

2026-02-04 08:15:42 ET More on AbbVie AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript AbbVie: The Dividend Does Not Lie AbbVie: Rocky Near-Term, Positive Long-Term AbbVie Non-GAAP EPS of $2.71 beats by $0.06, revenue of...

ABBV - AbbVie in charts: Revenues from Humira -26%, Skyrizi +32%, Rinvoq +29% Y/Y

2026-02-04 08:00:28 ET More on AbbVie AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript AbbVie: The Dividend Does Not Lie AbbVie: Rocky Near-Term, Positive Long-Term AbbVie Non-GAAP EPS of $10.00 beats by $7.35, revenue o...

ABBV - AbbVie Non-GAAP EPS of $10.00 beats by $7.35, revenue of $16.62B beats by $200M

2026-02-04 07:49:45 ET More on AbbVie AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript AbbVie: The Dividend Does Not Lie AbbVie: Rocky Near-Term, Positive Long-Term AbbVie Q4 Preview: Here's what to expect AbbVie...

ABBV - Expected US Company Earnings on Wednesday, February 4th, 2026

Central Garden & Pet Company (CENT) is expected to report $0.11 for Q1 2026 Eli Lilly and Company (LLY) is expected to report $6.99 for Q4 2025 The Ensign Group Inc. (ENSG) is expected to report $1.59 for Q4 2025 McKesson Corporation (MCK) is expected to report $9.31 for Q3 2026 ...

ABBV - 2 Healthcare Dividend Stocks That are Just What the Doctor Ordered

2026-02-03 17:55:00 ET Healthcare stocks are not known for healthy dividends. Great for growth, yes, but often so-so for dividend yields. The average medical large-cap stock's dividend yield was 1.67% at the end of 2025, sixth among the 11 sectors for large-cap stocks. Unlike utilities,...

ABBV - 3 things to look out for on Wednesday

2026-02-03 17:13:10 ET More on the markets How I Use XLB As A Leading Indicator For S&P 500 Kevin Warsh: Hawk, Dove... Or Something Else Entirely? India Dropping Russian Oil Demonstrates How Attractive America's Markets And Economy Are U.S. markets are st...

ABBV - DGRO: This Diversified Dividend Growth Fund Is Getting Pricey

2026-02-03 12:21:27 ET The iShares Core Dividend Growth ETF ( DGRO ) is a solid, well-constructed, and highly diversified dividend growth fund offered at a very reasonable expense ratio of 0.08%.... Read the full article on Seeking Alpha For further details see: DGRO...

ABBV - AbbVie Q4 Preview: Here's what to expect

2026-02-03 11:37:05 ET More on AbbVie AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript AbbVie: The Dividend Does Not Lie AbbVie: Rocky Near-Term, Positive Long-Term AbbVie seeks Rinvoq approval to treat vitiligo ...

ABBV - Allergan Aesthetics Continues Its Mission of Empowering Women Through the Faces of Natrelle® Testimonial Program

Allergan Aesthetics Continues Its Mission of Empowering Women Through the Faces of Natrelle® Testimonial Program PR Newswire The nationwide program invites eligible Natrelle ® breast augmentation and reconstruction patients to share their personal experiences. Natrel...

Previous 10 Next 10